NOV 19, 2016 12:18 PM PST

CRISPR Tested in Humans for the First Time

WRITTEN BY: Xuan Pham

In a historic, landmark clinical trial, Chinese researchers injected a patient with a shot of CRISPR-edited white blood cells in an effort to treat cancer.
 

Image credit: Pixabay.com


During the past few years, the CRISPR craze has taken hold of the scientific community, and it shows no signs of letting go. Due to its relatively low cost and high efficiency, CRISPR is revolutionizing the gene-editing game. Many of the breakthroughs using this technology are aimed at improving human health and curing diseases. But none so far has gone as far as using the technology in a human clinical trial.
 
The Chinese trial enrolled 10 participants who are diagnosed with metastatic non-small cell lung cancer. Because their cancer is advanced and has spread to other parts of the body, the patients have shown no signs of positive response to current available treatments. Their life expectancy is grim at only 6 months. In this context, the CRISPR technique may be the only tool left that can give these patients some hope.
 
To help these patients, Chinese researchers exploited the cut-and-paste mechanism of CRISPR to modify the patient’s own immune response cells. In particular, the team isolated the patients’ T cells – a type of white blood cell – to which they modified with CRISPR. The modification turns off a gene responsible for programmed cell death (PD-1). Scientists hope that with this switch off, the T cells can be unleashed to destroy cancer cells in the patients.
 


In essence, it’s a modernized version of immunotherapy – using the patient’s own immune system to combat the cancer invasion. The hope is that the patient’s cells will be much more adept at killing cancer than foreign drug compounds. Furthermore, this method should also minimize the risks to the patient’s healthy cells.
 
The injection was given to the patient as part of a Phase 1 trial, which means that scientists are trying to answer the question of the treatment’s safety. Results from this trial should inform us on how human bodies actually received CRISPR-edited cells and whether there are any unwanted side effects from this treatment. Whether the CRISPR-modified treatment will cure cancer will probably not be answered until years from now.
 
For now, the scientific community may receive this news with mixed reactions. While some may hail this as an exciting step towards genome engineering for human diseases, others are concerned that CRISPR will open the door for unethical tampering of the human genome (think designer babies). However, CRISPR seems unstoppable, and the US is also expected to approve its own medical trials with this technology soon too. 
 


Additional sources: Popular Science, Nature

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 27, 2021
Clinical & Molecular DX
No Batteries: Health Sensor Harvests Biomechanical Energy
APR 27, 2021
No Batteries: Health Sensor Harvests Biomechanical Energy
An international team of researchers has developed a wearable health monitor that works without the need for batteries. ...
MAY 18, 2021
Genetics & Genomics
Library Prep Methods for SARS-CoV-2 Sequencing: a Summary
MAY 18, 2021
Library Prep Methods for SARS-CoV-2 Sequencing: a Summary
As the SARS-CoV-2 virus continues to mutate, rapid sequencing of COVID-19-positive samples is more critical than ever. N ...
MAY 09, 2021
Genetics & Genomics
Another Neurodevelopmental Disorder is Discovered
MAY 09, 2021
Another Neurodevelopmental Disorder is Discovered
Researchers are identifying more rare disorders because of advances in genetic sequencing technologies, which have made ...
JUN 15, 2021
Cardiology
A Common Thread Among 20% of Sudden Cardiac Deaths
JUN 15, 2021
A Common Thread Among 20% of Sudden Cardiac Deaths
It's estimated that 450,000 Americans die from sudden heart conditions, and in about one in ten cases, the cause is unex ...
JUL 05, 2021
Genetics & Genomics
Genetics May Help Us Learn Who is at Risk From a Folate Deficiency
JUL 05, 2021
Genetics May Help Us Learn Who is at Risk From a Folate Deficiency
Folate is necessary for a healthy pregnancy; low folate levels can lead to neural tube defects. A lack of folate, a nutr ...
SEP 16, 2021
Drug Discovery & Development
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
SEP 16, 2021
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
According to the Population Reference Bureau, 40 million people in the United States are aged 65 and older. This nu ...
Loading Comments...